Long-term effects of clinical outcome with low and high dose in the Captopril in Heart Insufficient Patients Study (CHIPS)

Acta Cardiologica

Volumn 55, Issue 1, 2000, Pages 1-7

  Clement, Denis L ^a   De Buyzere, Marc ^a   Tomas, Marc ^b   Vanavermaete, Guy ^b  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

^b BRISTOL MYERS SQUIBB   (United States)

Author keywords

Chronic heart failure; Long term study; Low and high doses of captopril

Indexed keywords

CAPTOPRIL; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ADULT; AGED; ARTICLE; BELGIUM; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COUGHING; CREATININE BLOOD LEVEL; DISEASE COURSE; DISEASE SEVERITY; DOSE RESPONSE; FEMALE; FOLLOW UP; HEART FAILURE; HOSPITALIZATION; HUMAN; HYPOTENSION; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; VERTIGO;

EID: 0342470464     PISSN: 00015385     EISSN: None     Source Type: Journal    
DOI: 10.2143/AC.55.1.2005711     Document Type: Article

References (10)

1. The ISIS-4 (Fourth International Study of Infarct Survival) Collaborative Group. A randomized factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulfate in 58050 patients with suspected acute myocardial infarction. The Lancet 1995; 345: 669-685.
2. Pfeffer MA, Braunwald E, Moyé LA, Basta L, Brown EJ, Cuddy TE, Davis BR, Geltman EM, Goldman S, Flaker GC, Klein M, Lamas GA, Packer M, Rouleau J, Rouleau JL, Rutherford J, Wertheimer JH, Hawkins M, on behalf of the SAVE investigators. Effects of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. New Engl J Med 1992; 327: 669-677.
3. The Consensus Trial Study Group: Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). New Engl J Med 1987; 316: 1429-1435.
4. The SOLVD Investigators. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. New Engl J Med 1991; 325: 293-302.
5. Garg R, Yusuf S, for the Collaborative Group on ACE Inhibitor Trials. Overview of randomized trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure. JAMA 1995; 273: 1450-1456.
6. Houghton AR, Cowley AJ. Why are angiotensin converting enzyme inhibitors underutilised in the treatment of heart failure by general practitioners? Int J Cardiol 1997; 59: 7-10.
7. Pacher R, Globits S, Bergler-Klein J, Teufelsbauer H, Wutte M, Baumgartner W, Ogris E, Glogar D. Clinical and neurohumoral response of patients with severe congestive heart failure treated with two different captopril doses. Eur Heart J 1993; 14: 273-278.
8. Vagelos R, Yee G, Boyle M, Moore C, Prikazsky L, Willson K, Fowler M. Failure of low but not high dose chronic enalapril therapy to suppress serum angiotensin converting enzyme (ACE) activity in heart failure. J Am Coll Cardiol 1992; 19: 145 (Abstr 741-1).
9. The NETWORK investigators. Clinical outcome with enalapril in symptomatic chronic heart failure; a dose comparison. Eur Heart J 1998; 19: 481-489.
10. Packer M, Poole-Wilson P, Amstrong P, Cleland J, Horowitz J., Massie B, Ryden L. Comparative effect of low-dose versus high-dose lisinopril on survival and major events in chronic heart failure: the Assessment of Treatment with Lisinopril And Survival Study (ATLAS). Eur Heart J 1998; 19: 142 (Abst 905).